Abstracts - faqs.org

Abstracts

Health

Search abstracts:
Abstracts » Health

Incidence of adverse reactions in HIV patients treated with protease inhibitors: a cohort study

Article Abstract:

The protease inhibitor ritonavir appears to have more side effects than other protease inhibitors, according to a study of 1,207 patients who were taking a protease inhibitor. Saquinavir HGC and nelfinavir had the fewest side effects.

Author: Bonfanti, Paolo, Valsecchi, Laura, Parazzini, Fabio, Carradori, Silvia, Pusterla, Luigi, Fortuna, Paolo, Timillero, Lia, Alessi, Federica, Ghiselli, Giancarlo, Gabbuti, Andrea, Di Cintio, Elisabetta, Martinelli, Canio, Faggion, Ivano, Landonio, Simona, Quirino, Tiziana
Publisher: Lippincott Williams & Wilkins, WK Health
Publication Name: Journal of Acquired Immune Deficiency Syndromes (1999)
Subject: Health
ISSN: 1525-4135
Year: 2000
Ritonavir, Protease inhibitors

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


An Italian approach to postmarketing monitoring: Preliminary results from the SCOLTA (Surveillance Cohort Long-Term Toxicity Antiretrovirals) project on the safety of Lopinavir/Ritonavir

Article Abstract:

The SCOLTA project (Surveillance Cohort Long-term Toxicity Antiretrovirals) is a system for online surveying of adverse reactions to commercialized antiretroviral drugs and a 'sentinel' for unexpected and late adverse reactions arising during any antiretroviral treatment. These data collection method gives timely real-life information from which to assess the impact of short-and long-term toxicity of new antiretroviral drugs.

Author: Carradori, Silvia, Martinelli, Canio, Quirino, Tiziana, Bonfati, Paolo, Ricci, Elena, Parruti, Giustino, Armignacco, Orlando, Magnani, Carlo
Publisher: Lippincott Williams & Wilkins, WK Health
Publication Name: Journal of Acquired Immune Deficiency Syndromes (1999)
Subject: Health
ISSN: 1525-4135
Year: 2005
Italy, General services, Science & research, Research, Surveys, Company systems management, Information management, Antiviral agents, Highly active antiretroviral therapy, Antiretroviral agents, Internet marketing

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


HIV and metabolic syndrome: A comparison with the general population

Article Abstract:

The prevalence of metabolic syndrome (MS) in HIV-positive patients is compared with that of a sample of general Italian population. It is found that the risk of MS is greater in HIV-infected patients than in the normal people.

Author: Bonfanti, Paolo, Pusterla, Luigi, Quirino, Tiziana, Mancia, Giuseppe, Ricci, Elena, Giannattasio, Christina, Facchetti, Rita, Rosella, Elena, Franzetti, Marzia, Cordier, Laura, Bombelli, Michele, Sega, Roberto
Publisher: Lippincott Williams & Wilkins, WK Health
Publication Name: Journal of Acquired Immune Deficiency Syndromes (1999)
Subject: Health
ISSN: 1525-4135
Year: 2007
Health aspects, Risk factors, HIV infection, HIV infections, Metabolic syndrome X, Clinical report

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Subjects list: Complications and side effects
Similar abstracts:
  • Abstracts: Role of protease inhibitors in preventing recurrent oral candidosis in patients with HIV infection: a prospective case-control study
  • Abstracts: A Capitol idea: visitor center puts construction safety first. Power struggle
  • Abstracts: A comparison of nefazodone, the cognitive behavioral-analysis system of psychotherapy, and their combination for the treatment of chronic depression
  • Abstracts: Endometrial microbial colonization and plasma cell endometritis after spontaneous or indicated preterm versus term delivery
  • Abstracts: Efavirenz- and adefovir dipivoxil-based salvage therapy in highly treatment-experienced patients: clinical and genotypic predictors of virologic response
This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.
Some parts © 2025 Advameg, Inc.